Ekso Bionics Holdings, Inc.
EKSO
$3.49
$0.010.29%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 10.78% | 24.20% | 25.45% | 26.59% | 22.84% |
| Total Depreciation and Amortization | -5.97% | -6.51% | -5.30% | 7.74% | 30.94% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -92.62% | -23.56% | 18.33% | -22.27% | 27.21% |
| Change in Net Operating Assets | 110.23% | 15.07% | -333.10% | 14.71% | -1,202.14% |
| Cash from Operations | 17.65% | 26.19% | 18.32% | 29.17% | 17.06% |
| Capital Expenditure | -16.18% | 68.29% | 76.43% | 64.67% | 76.63% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -16.18% | 68.29% | 76.43% | 98.85% | 98.71% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -33.26% | -99.68% | -299.36% | -- | -- |
| Issuance of Common Stock | 108.94% | 92.03% | 1,264.75% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 127.86% | 90.79% | 2,132.47% | -- | -- |
| Foreign Exchange rate Adjustments | 257.14% | 96.30% | -29.17% | -205.26% | -216.67% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 91.34% | 90.04% | 81.96% | 91.45% | 60.11% |